Search

Your search keyword '"Visner GA"' showing total 67 results

Search Constraints

Start Over You searched for: Author "Visner GA" Remove constraint Author: "Visner GA"
67 results on '"Visner GA"'

Search Results

3. Novel action of indoleamine 2,3-dioxygenase attenuating acute lung allograft injury.

4. Heme oxygenase-1 expression in human lungs with cystic fibrosis and cytoprotective effects against Pseudomonas aeruginosa in vitro.

5. Role of transbronchial biopsies in pediatric lung diseases.

6. Pediatric Lung Transplantation for Pulmonary Vascular Diseases: Recent Advances and Challenges.

7. Exercise-Induced Pulmonary Hypertension in Long-Term Survivors of Congenital Diaphragmatic Hernia.

8. Outcomes of surgical treatment of tracheobronchomalacia in children.

9. The IPTA Nashville consensus conference on Post-Transplant lymphoproliferative disorders after solid organ transplantation in children: II-consensus guidelines for prevention.

10. A novel ex vivo tracheobronchomalacia model for airway stent testing and in vivo model refinement.

11. Recovery of right ventricular function after bilateral lung transplantation for pediatric pulmonary hypertension.

12. Auto-inflammation and auto-immunity pathways are associated with emergence of BOS in pediatric lung transplantation.

13. miR-21 antagonism reprograms macrophage metabolism and abrogates chronic allograft vasculopathy.

14. Pediatric lung transplant: Correlation of pretransplant condition with post-transplant outcomes.

15. Current evaluation and management of plastic bronchitis in the pediatric population.

16. Mitochondrial transplantation enhances murine lung viability and recovery after ischemia-reperfusion injury.

17. Descending Aortopexy and Posterior Tracheopexy for Severe Tracheomalacia and Left Mainstem Bronchomalacia.

18. Mitochondrial transplantation prolongs cold ischemia time in murine heart transplantation.

19. Purinergic P2X4 receptors and mitochondrial ATP production regulate T cell migration.

20. Anellovirus loads are associated with outcomes in pediatric lung transplantation.

21. Posterior Tracheopexy for Severe Tracheomalacia Associated with Esophageal Atresia (EA): Primary Treatment at the Time of Initial EA Repair versus Secondary Treatment.

22. Transplant center volume and outcomes in lung transplantation for cystic fibrosis.

24. Inhibition of the purinergic pathway prolongs mouse lung allograft survival.

25. Indoleamine 2,3-dioxygenase and metabolites protect murine lung allografts and impair the calcium mobilization of T cells.

26. Inhibitory effects of pirfenidone on dendritic cells and lung allograft rejection.

27. Pirfenidone inhibits T-cell activation, proliferation, cytokine and chemokine production, and host alloresponses.

28. Reduced cytotoxic function of effector CD8+ T cells is responsible for indoleamine 2,3-dioxygenase-dependent immune suppression.

29. Nonviral gene delivery with indoleamine 2,3-dioxygenase targeting pulmonary endothelium protects against ischemia-reperfusion injury.

30. Applications of Sleeping Beauty transposons for nonviral gene therapy.

31. Sleeping Beauty-based gene therapy with indoleamine 2,3-dioxygenase inhibits lung allograft fibrosis.

32. Bone marrow stem cells as a vehicle for delivery of heme oxygenase-1 gene.

33. Heme oxygenase-1 mediates the protective effects of rapamycin in monocrotaline-induced pulmonary hypertension.

34. Pirfenidone inhibits obliterative airway disease in mouse tracheal allografts.

35. Pirfenidone inhibits inflammatory responses and ameliorates allograft injury in a rat lung transplant model.

36. Bone marrow-derived stem-cell repopulation contributes minimally to the Type II pneumocyte pool in transplanted human lungs.

37. Pirfenidone inhibits lung allograft fibrosis through L-arginine-arginase pathway.

38. Heme-oxygenase-1 expression correlates with severity of acute cellular rejection in lung transplantation.

39. Graft protective effects of heme oxygenase 1 in mouse tracheal transplant-related obliterative bronchiolitis.

40. Toxic serum trough concentrations after administration of nebulized tobramycin.

41. Rapamycin induces heme oxygenase-1 in human pulmonary vascular cells: implications in the antiproliferative response to rapamycin.

42. Increased expression of heme oxygenase-1 in human lung transplantation.

43. Analysis of early deaths after isolated lung transplantation.

44. Geneticin induces endogenous heme oxygenase-1 expression: implication in transfection studies.

45. Smad7-dependent regulation of heme oxygenase-1 by transforming growth factor-beta in human renal epithelial cells.

46. Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis.

47. Transcriptional regulation and structural organization of the human cytosolic phospholipase A(2) gene.

48. Iron regulates hyperoxia-dependent human heme oxygenase 1 gene expression in pulmonary endothelial cells.

49. Linoleyl hydroperoxide transcriptionally upregulates heme oxygenase-1 gene expression in human renal epithelial and aortic endothelial cells.

Catalog

Books, media, physical & digital resources